FTC Closes Investigation Into CVS Caremark Practices

WOONSOCKET, R.I. — The Federal Trade Commission (FTC) has closed a two-year investigation into pharmacy benefit management CVS Caremark's business practices, the drug store chain said on Friday.

While the FTC made no allegations of antitrust law violations or anti-competitive behavior, the agency alleged from 2007 until at least November 2008, CVS subsidiary Rx America posted incorrect prices for certain Medicare Part D prescription drugs at CVS and Wa

Register to view the full article

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.